| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/02/2009 | CA2189947C Use of von willebrand factor and pharmaceutical formulation |
| 06/02/2009 | CA2178208C Purification of vitamin-k dependent proteins by membrane chromatography |
| 05/28/2009 | WO2009066562A1 Differentiation promoter and/or proliferation promoter for erythrocyte stem cells, use of methionine for preventing or treating senile anemia, and compositions containing methionine |
| 05/28/2009 | WO2009066113A1 Improved anti-platelet compositions and methods |
| 05/28/2009 | WO2009065918A1 Stabilisation of liquid-formulated factor vii(a) polypeptides by aldehyde-containing compounds |
| 05/28/2009 | WO2009065472A1 {[5-(phenyl)-6-phenylpyrrolo[2,1-f][2,1,4]triazin-4-yl]amino}carboxylic acid derivatives and related compounds as prostacyclin (pgi2) ip receptor activators for treating cardiovascular disorders |
| 05/28/2009 | WO2009065193A1 Treatment of aspirin resistance with betaine and/or betaine enriched molasses |
| 05/28/2009 | US20090137845 Novel 4-Dedimethylaminotetracycline derivatives |
| 05/28/2009 | US20090137600 Antiplatelet agent and process for producing the same |
| 05/28/2009 | US20090137576 Novel Piperidine Derivative |
| 05/28/2009 | US20090137567 Methods for Treating Blood Disorders |
| 05/28/2009 | US20090137561 Substituted biphenyl GPR40 modulators |
| 05/28/2009 | US20090137535 Substituted oxazolidinone derivatives |
| 05/28/2009 | US20090137498 Substituted benzene derivatives or salts thereof |
| 05/28/2009 | US20090137466 Use of GLP-1, Exendin and Agonists Thereof To Delay or Prevent Cardiac Remodeling |
| 05/28/2009 | US20090137464 Therapeutic fibrin-derived peptides and uses thereof |
| 05/28/2009 | US20090136648 Platelet aggregation inhibitor and health food effective in inhibiting platelet aggregation |
| 05/28/2009 | US20090136557 Methods, Devices, And Compositions For Lysis Of Occlusive Blood Clots While Sparing Wound Sealing Clots |
| 05/28/2009 | US20090136474 Stabilized Protease Composition |
| 05/28/2009 | US20090136467 Apolipoprotein analogues |
| 05/28/2009 | US20090136442 Erythropoietin receptor peptide formulations and uses |
| 05/28/2009 | US20090136419 parenterally administering a dose of samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and carboplatin or taxoids; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 05/28/2009 | DE102007056253A1 Use of homogenized sloe composition, obtained by heating, e.g. for liquefaction of body fluids, reduction of surface tension, for the reduction of body odor, preferably excrement and sweat, to promote hair growth and as antibiotic |
| 05/28/2009 | CA2703887A1 {[5-(phenyl)-6-phenylpyrrolo[2,1-f][2,1,4]triazin-4-yl]amino}carboxylic acid derivatives and related compounds as prostacyclin (pgi2) ip receptor activators for treating cardiovascular disorders |
| 05/27/2009 | EP2062890A1 Tricyclic thrombin receptor antagonist |
| 05/27/2009 | EP2062879A1 Heterocyclic inhibitors of p38 |
| 05/27/2009 | EP2062589A1 Therapeutic and/or ameliorating agent for disseminated intravascular coagulation |
| 05/27/2009 | EP2062580A1 Use of dipyridamole or mopidamole for treatment and prevention of thromboembolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of trombin receptors |
| 05/27/2009 | EP2061793A2 Kw-3902 conjugates that do not cross the blood-brain barrier |
| 05/27/2009 | EP2061756A2 2-aminocarbonylphenylamino-2-phenilacetamides as factor viia inhibitors useful as anticoagulants |
| 05/27/2009 | EP2061755A1 Tricyclic compounds useful in treating iron disorders |
| 05/27/2009 | EP2061754A1 Biaryl and biheteroaryl compounds useful in treating iron disorders |
| 05/27/2009 | EP2061560A2 Bcl inhibitors for treating platelet excess |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | EP1351672B1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 05/27/2009 | EP1292678B1 G-protein coupled receptors |
| 05/27/2009 | EP1250140B1 Combination ofan abl-, pdgf-receptor- and/or kit receptor-tyrosine kinase inhibitor with an organic compound capable of binding to alpha1-acidic glycoprotein |
| 05/27/2009 | EP0832228B1 Modified hemoglobin-like compounds and methods of purifying same |
| 05/27/2009 | CN101443351A Modified molecules which promote hematopoiesis |
| 05/27/2009 | CN101443326A Substituted prolinamides, production thereof and their use as drugs |
| 05/27/2009 | CN101443004A Formulations and methods for vascular permeability-related diseases or conditions |
| 05/27/2009 | CN101442974A Paste for use as a bandage on mucous membranes of the oral cavity or on the skin |
| 05/27/2009 | CN101440369A Expression method of deleted zonula occludens toxin gene of Vibrio cholerae and use |
| 05/27/2009 | CN101440085A Thrombin inhibitors containing guanidine heterocyclic compound and preparation thereof |
| 05/27/2009 | CN101439133A Chinese medicine prescription for quickly treating nephroma and ascites symptoms of broiler chickens |
| 05/27/2009 | CN101439123A Method for preparing formulation containing four ingredients |
| 05/27/2009 | CN101439098A Chinese medicine for treating bleeding disease and preparation method thereof |
| 05/27/2009 | CN101439089A Medicament containing oxymatrine |
| 05/27/2009 | CN101439088A Medicament for promoting leucocyte hyperplasia |
| 05/27/2009 | CN101439072A Application of Chinese medicinal composition in preparing medicament for preventing and treating thrombus |
| 05/27/2009 | CN101439047A Technological process for improving stable FVII yield of human prothrombin complexes |
| 05/27/2009 | CN101439037A Alprostadil lipid complexes and micelle composition thereof for injection |
| 05/27/2009 | CN101439025A Silymarin high-efficient long-acting preparation and production method thereof |
| 05/27/2009 | CN100491378C Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharamaceutical compositions comprising them and their use as a medicine |
| 05/27/2009 | CN100491374C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors |
| 05/27/2009 | CN100491356C Compounds exhibiting thrombopoietin receptor agaonism |
| 05/27/2009 | CN100491348C Thrombosis resisting preparation |
| 05/27/2009 | CN100490901C Tetramethylpyrazine derivatives modified silk fibroin protein fiber anti-coagulant material and its preparation method |
| 05/27/2009 | CN100490801C Ginkgolide B dropping pill and its preparing method |
| 05/27/2009 | CN100490783C No-sugar Mailuoning granule and its preparing process and quality control method |
| 05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/26/2009 | US7538118 6-aminomorphinane derivatives, method for production and use thereof |
| 05/26/2009 | US7538089 Anti-inflammatory compounds and uses thereof |
| 05/26/2009 | US7537763 Tumor necrosis factor specific immunoglobulin for use in treatment and prevention of tumor disorder; tissue targeted therapy |
| 05/26/2009 | CA2399870C Topically applied clotting material |
| 05/26/2009 | CA2387201C Tetrahydroquinoline derivatives |
| 05/26/2009 | CA2355077C Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same |
| 05/26/2009 | CA2344058C Diaminopropionic acid derivatives |
| 05/26/2009 | CA2295247C Compositions containing thrombin and microfibrillar collagen |
| 05/22/2009 | WO2009065142A2 Use of nitrite salts in chronic ischemia |
| 05/22/2009 | WO2009063993A1 Fused pyridine derivative and use thereof |
| 05/22/2009 | WO2009063116A1 Use of microparticles for vaccines and the release of biologically active molecules |
| 05/22/2009 | WO2009063029A2 Substituted amides, manufacturing and use thereof as medicaments |
| 05/22/2009 | WO2009063028A2 Substituted amides, manufacturing and use thereof as medicaments |
| 05/22/2009 | WO2009063018A1 Aqueous iron dextran preparation having one or more para-hydroxybenzoate compounds and/or salts thereof |
| 05/22/2009 | WO2009029836A3 Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substitutes |
| 05/21/2009 | US20090131668 4-oxo-4,6,7,8-Tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds |
| 05/21/2009 | US20090131492 Indole derivatives as CFTR modulators |
| 05/21/2009 | US20090131487 calixarenes having acyclic isophthalic acid groups attached, used as target for platelet derived growth factors or vascular endothelial growth factors, angiogenesis inhibitors, antiproliferative, antitumor or anticarcinogenic agents |
| 05/21/2009 | US20090131456 Caspase inhibitors and uses thereof |
| 05/21/2009 | US20090131418 Spiroazacyclic compounds as monoamine receptor modulators |
| 05/21/2009 | US20090131411 monoamidino-containing compounds having good bioavailability and/or solubility, used as potent and specific inhibitors of blood coagulation in mammals, and as therapeutic agents for disease states characterized by coagulation disorders |
| 05/21/2009 | US20090131404 Combinations |
| 05/21/2009 | US20090131379 Vitamin d receptor activators and methods of making |
| 05/21/2009 | US20090130681 21132, a Human G-protein coupled receptor family member and uses therefor |
| 05/21/2009 | US20090130095 Composition comprising tumor necrosis factor (CD40) specific immunoglobulin for treatment and prevention of autoimmune diseases |
| 05/21/2009 | US20090130094 Cytotoxic Antibodies Directed Against Antibodies Inhibiting Factor VIII |
| 05/21/2009 | US20090130085 Amidino-Compounds for Stabilizing Factor VII Polypeptide Formulations |
| 05/20/2009 | EP2060569A1 Ethyl 3-[(2-{[4-Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionate methanesulfonate hemihydrate and its use as a medicament |
| 05/20/2009 | EP2059806A2 Modified annexin proteins and methods for their use in platelet storage and transfusion |
| 05/20/2009 | EP2059251A2 Use of unactivated calcium exchanged zeolites in hemostatic devices and products |
| 05/20/2009 | EP1354888B1 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 05/20/2009 | EP1331944B1 Use of cd28-specific monoclonal antibodies for stimulating blood cells that lack cd28 |
| 05/20/2009 | DE60226032T2 Neue imidazolidinderivate, deren herstellung und verwendung als vla4-antagonisten New imidazolidine derivatives, their preparation and use as VLA4 antagonists |
| 05/20/2009 | DE102007054786A1 Trisubstituierte Furopyrimidine und ihre Verwendung Trisubstituted Furopyrimidine and their use |
| 05/20/2009 | CN201239351Y Tablet capsule containing clopidogrel hydrogensulfate tablet and acetylsalicylic acid tablet |
| 05/20/2009 | CN101437502A Perfluocarbon gaseous transfer emulsion composition for medicament and biology, and obtaining method thereof and medicament |
| 05/20/2009 | CN101434964A Cholera toxin B subunit and lumbrokinase fusion gene, as well as recombinant vector and host cell including the same |
| 05/20/2009 | CN101433718A Biodegradable polypeptide vesicle loaded with hemoglobin and preparation method thereof |
| 05/20/2009 | CN101433706A Method for preparing decoction for invigorating spleen |